A systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on body composition and blood lipids: Exploring the factors responsible for variability in their efficacy

Nutrients

Volumn 9, Issue 7, 2017, Pages

  González Sarrías, Antonio ^a   Combet, Emilie ^b   Pinto, Paula ^c   Mena, Pedro ^d   Dall’Asta, Margherita ^d   Garcia Aloy, Mar ^e,f   Rodríguez Mateos, Ana ^g   Gibney, Eileen R ^h   Dumont, Julie ⁱ   Massaro, Marika ^j   Sánchez Meca, Julio ^k   Morand, Christine ^l   García Conesa, María Teresa ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c POLYTECHNIC INSTITUTE OF SANTARÉM   (Portugal)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Instituto de Investigación Biosanitaria Ibs   (Spain)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

ⁱ UNIV LILLE   (France)

^j INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^k UNIVERSITY OF MURCIA   (Spain)

^l INRA and University of Auvergne   (France)

more..

Author keywords

Apple; Blood lipids; Body mass index; Cardiometabolic disorders; Cocoa; Flavanols; Interindividual variability; Meta analysis; Tea; Waist circumference

Indexed keywords

EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABNORMAL BLOOD PRESSURE; APPLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CACAO; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; HUMAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; META ANALYSIS; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVIEW; SMOKING; SYSTEMATIC REVIEW; TEA; WAIST CIRCUMFERENCE;

EID: 85024126867     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9070746     Document Type: Review

References (183)

1. Pucci, G.; Alcidi, R.; Tap, L.; Battista, F.; Mattace-Raso, F.; Schillaci, G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol. Res. 2017, 120, 34–42.
2. Nothlings, U.; Schulze, M.B.; Weikert, C.; Boeing, H.; van der Schouw, Y.T.; Bamia, C.; Benetou, V.; Lagiou, P.; Krogh, V.; Beulens, J.W. et al. Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a european diabetic population. J. Nutr. 2008, 138, 775–781.
3. Howes, M.J.; Simmonds, M.S. The role of phytochemicals as micronutrients in health and disease. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 558–566.
4. Wang, S.; Moustaid-Moussa, N.; Chen, L.; Mo, H.; Shastri, A.; Su, R.; Bapat, P.; Kwun, I.; Shen, C.L. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 2014, 25, 1–18.
5. Grosso, G.; Micek, A.; Godos, J.; Pajak, A.; Sciacca, S.; Galvano, F.; Giovannucci, E.L. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: Systematic review and dose-response meta-analysis. Am. J. Epidemiol. 2017, 1–13, doi:10.1093/aje/kww207.
6. Rienks, J.; Barbaresko, J.; Nothlings, U. Association of polyphenol biomarkers with cardiovascular disease and mortality risk: A systematic review and meta-analysis of observational studies. Nutrients 2017, 9, doi:10.3390/nu9040415.
7. Menezes, R.; Rodriguez-Mateos, A.; Kaltsatou, A.; Gonzalez-Sarrias, A.; Greyling, A.; Giannaki, C.; Andres-Lacueva, C.; Milenkovic, D.; Gibney, E.R.; Dumont, J. et al. Impact of flavonols on cardiometabolic biomarkers: A meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. Nutrients 2017, 9, 117, doi:10.3390/nu9020117.
8. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.; Tognolini, M.; Borges, G.; Crozier, A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013, 18, 1818–1892.
9. Rodriguez-Mateos, A.; Vauzour, D.; Krueger, C.G.; Shanmuganayagam, D.; Reed, J.; Calani, L.; Mena, P.; Del Rio, D.; Crozier, A. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: An update. Arch. Toxicol. 2014, 88, 1803–1853.
10. Neveu, V.; Perez-Jiménez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.; Wishart, D. et al. Phenol-explorer: An online comprehensive database on polyphenol contents in foods. Database 2010, doi:10.1093/database/bap024.
11. Vogiatzoglou, A.; Mulligan, A.A.; Luben, R.N.; Lentjes, M.A.; Heiss, C.; Kelm, M.; Merx, M.W.; Spencer, J.P.; Schroeter, H.; Kuhnle, G.G. Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the european union. Br. J. Nutr. 2014, 111, 1463–1473.
12. Actis-Goretta, L.; Leveques, A.; Giuffrida, F.; Romanov-Michailidis, F.; Viton, F.; Barron, D.; Duenas-Paton, M.; Gonzalez-Manzano, S.; Santos-Buelga, C.; Williamson, G. et al. Elucidation of (−)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 2012, 53, 787–795.
13. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S–242S.
14. Ottaviani, J.I.; Kwik-Uribe, C.; Keen, C.L.; Schroeter, H. Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am. J. Clin. Nutr. 2012, 95, 851–858.
15. Manach, C.; Milenkovic, D.; Van de Wiele, T.; Rodriguez-Mateos, A.; de Roos, B.; Garcia-Conesa, M.T.; Landberg, R.; Gibney, E.R.; Heinonen, M.; Tomas-Barberan, F. et al. Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Mol. Nutr. Food Res. 2017, doi:10.1002/mnfr.201600557.
16. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gotzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009, 6, e1000100.
17. Higgins, J.P.T.; Green, S. (Eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011. Available online: http://handbook-5-1.cochrane.org/(accessed on 15 May 2015).
18. Centre for Reviews and Dissemination (CRD). Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care; CRD, University of York: York, UK, 2009.
19. Higgins, J.P.T.; Altman, D.G.; Sterne, J.A.C. (Eds.) Assessing Risk of Bias in Included Studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]; The Cochrane Collaboration, 2011. Available online: http://handbook-5-1.cochrane.org/(accessed on 15 October 2015).
20. Borenstein, M.J.; Hedges, L.V.; Higgins, J.; Rothstein, H. Comprehensive Meta-Analysis Vers. 3.3 [Computer Program]; Biostat, Inc.: Englewood, NJ, USA, 2014.
21. Akazome, Y.; Kametani, N.; Kanda, T.; Shimasaki, H.; Kobayashi, S. Evaluation of safety of excessive intake and efficacy of long-term intake of beverages containing apple polyphenols. J. Oleo Sci. 2010, 59, 321–338.
22. Al-Faris, N.A. Short-term consumption of a dark chocolate containing flavanols is followed by a significant decrease in normotensive population. Pak. J. Nutr. 2008, 7, 773–781.
23. Auvichayapat, P.; Prapochanung, M.; Tunkamnerdthai, O.; Sripanidkulchai, B.O.; Auvichayapat, N.; Thinkhamrop, B.; Kunhasura, S.; Wongpratoom, S.; Sinawat, S.; Hongprapas, P. Effectiveness of green tea on weight reduction in obese thais: A randomized, controlled trial. Physiol. Behav. 2008, 93, 486–491.
24. Baba, S.; Natsume, M.; Yasuda, A.; Nakamura, Y.; Tamura, T.; Osakabe, N.; Kanegae, M.; Kondo, K. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder. J. Nutr. 2007, 137, 1436–1441.
25. Baba, S.; Osakabe, N.; Kato, Y.; Natsume, M.; Yasuda, A.; Kido, T.; Fukuda, K.; Muto, Y.; Kondo, K. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am. J. Clin. Nutr. 2007, 85, 709–717.
26. Bahorun, T.; Luximon-Ramma, A.; Neergheen-Bhujun, V.S.; Gunness, T.K.; Googoolye, K.; Auger, C.; Crozier, A.; Aruoma, O.I. The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev. Med. 2012, 54, S98–S102.
27. Bajerska, J.; Mildner-Szkudlarz, S.; Walkowiak, J. Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: A pilot study. J. Med. Food 2015, 18, 698–705.
28. Balzer, J.; Rassaf, T.; Heiss, C.; Kleinbongard, P.; Lauer, T.; Merx, M.; Heussen, N.; Gross, H.B.; Keen, C.L.; Schroeter, H. et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol. 2008, 51, 2141–2149.
29. Barth, S.W.; Koch, T.C.; Watzl, B.; Dietrich, H.; Will, F.; Bub, A. Moderate effects of apple juice consumption on obesity-related markers in obese men: Impact of diet-gene interaction on body fat content. Eur. J. Nutr. 2012, 51, 841–850.
30. Basu, A.; Du, M.; Sanchez, K.; Leyva, M.J.; Betts, N.M.; Blevins, S.; Wu, M.; Aston, C.E.; Lyons, T.J. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2011, 27, 206–213.
31. Basu, A.; Sanchez, K.; Leyva, M.J.; Wu, M.; Betts, N.M.; Aston, C.E.; Lyons, T.J. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 2010, 29, 31–40.
32. Batista Gde, A.; Cunha, C.L.; Scartezini, M.; von der Heyde, R.; Bitencourt, M.G.; Melo, S.F. Prospective double-blind crossover study of camellia sinensis (green tea) in dyslipidemias. Arq. Bras. Cardiol. 2009, 93, 128–134.
33. Belcaro, G.; Ledda, A.; Hu, S.; Cesarone, M.R.; Feragalli, B.; Dugall, M. Greenselect phytosome for borderline metabolic syndrome. Evid. Based Complement. Altern. Med. 2013, 2013, 869061.
34. Bingham, S.A.; Vorster, H.; Jerling, J.C.; Magee, E.; Mulligan, A.; Runswick, S.A.; Cummings, J.H. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br. J. Nutr. 1997, 78, 41–55.
35. Bogdanski, P.; Suliburska, J.; Szulinska, M.; Stepien, M.; Pupek-Musialik, D.; Jablecka, A. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr. Res. 2012, 32, 421–427.
36. Bohn, S.K.; Croft, K.D.; Burrows, S.; Puddey, I.B.; Mulder, T.P.; Fuchs, D.; Woodman, R.J.; Hodgson, J.M. Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: A randomized controlled trial. Food Funct. 2014, 5, 1613–1620.
37. Bondia-Pons, I.; Poho, P.; Bozzetto, L.; Vetrani, C.; Patti, L.; Aura, A.M.; Annuzzi, G.; Hyotylainen, T.; Rivellese, A.A.; Oresic, M. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk. Mol. Nutr. Food Res. 2014, 58, 1873–1882.
38. Brown, A.L.; Lane, J.; Coverly, J.; Stocks, J.; Jackson, S.; Stephen, A.; Bluck, L.; Coward, A.; Hendrickx, H. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial. Br. J. Nutr. 2009, 101, 886-894.
39. Brown, A.L.; Lane, J.; Holyoak, C.; Nicol, B.; Mayes, A.E.; Dadd, T. Health effects of green tea catechins in overweight and obese men: A randomised controlled cross-over trial. Br. J. Nutr. 2011, 106, 1880–1889.
40. Cardoso, G.A.; Salgado, J.M.; Cesar, M.D.C.; Donado-Pestana, C.M. The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women. J. Med. Food. 2013, 16, 120–127.
41. Chai, S.C.; Hooshmand, S.; Saadat, R.L.; Payton, M.E.; Brummel-Smith, K.; Arjmandi, B.H. Daily apple versus dried plum: Impact on cardiovascular disease risk factors in postmenopausal women. J. Acad. Nutr. Diet. 2012, 112, 1158–1168.
42. Chan, E.K.; Quach, J.; Mensah, F.K.; Sung, V.; Cheung, M.; Wake, M. Dark chocolate for children’s blood pressure: Randomised trial. Arch. Dis. Child. 2012, 97, 637–640.
43. Chen, I.J.; Liu, C.Y.; Chiu, J.P.; Hsu, C.H. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2016, 35, 592–599.
44. Coimbra, S.; Santos-Silva, A.; Rocha-Pereira, P.; Rocha, S.; Castro, E. Green tea consumption improves plasma lipid profiles in adults. Nutr. Res. 2006, 26, 604–607.
45. Crew, K.D.; Ho, K.A.; Brown, P.; Greenlee, H.; Bevers, T.B.; Arun, B.; Sneige, N.; Hudis, C.; McArthur, H.L.; Chang, J. et al. Effects of a green tea extract, polyphenon e, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J. Hum. Nutr. Diet. 2015, 28, 272–282.
46. Crews, W.D., Jr.; Harrison, D.W.; Wright, J.W. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: Clinical findings from a sample of healthy, cognitively intact older adults. Am. J. Clin. Nutr. 2008, 87, 872–880.
47. Davies, M.J.; Judd, J.T.; Baer, D.J.; Clevidence, B.A.; Paul, D.R.; Edwards, A.J.; Wiseman, S.A.; Muesing, R.A.; Chen, S.C. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J. Nutr. 2003, 133, 3298S–3302S.
48. Davison, K.; Coates, A.M.; Buckley, J.D.; Howe, P.R. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. 2008, 32, 1289–1296.
49. Romero-Prado, M.M.J.; Curiel-Beltran, J.A.; Miramontes-Espino, M.V.; Cardona-Munoz, E.G.; Rios-Arellano, A.; Balam-Salazar, L.B. Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure. Basic Clin. Pharmacol. Toxicol. 2015, 117, 57–64.
50. De la Torre, R.; De Sola, S.; Pons, M.; Duchon, A.; de Lagran, M.M.; Farre, M.; Fito, M.; Benejam, B.; Langohr, K.; Rodriguez, J. et al. Epigallocatechin-3-gallate, a dyrk1a inhibitor, rescues cognitive deficits in down syndrome mouse models and in humans. Mol. Nutr. Food Res. 2014, 58, 278–288.
51. Desideri, G.; Kwik-Uribe, C.; Grassi, D.; Necozione, S.; Ghiadoni, L.; Mastroiacovo, D.; Raffaele, A.; Ferri, L.; Bocale, R.; Lechiara, M.C. et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The cocoa, cognition, and aging (cocoa) study. Hypertension 2012, 60, 794–801.
52. Diepvens, K.; Kovacs, E.M.; Vogels, N.; Westerterp-Plantenga, M.S. Metabolic effects of green tea and of phases of weight loss. Physiol. Behav. 2006, 87, 185–191.
53. Dower, J.I.; Geleijnse, J.M.; Gijsbers, L.; Zock, P.L.; Kromhout, D.; Hollman, P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015, 101, 914–921.
54. Duffy, S.J.; Keaney, J.F., Jr.; Holbrook, M.; Gokce, N.; Swerdloff, P.L.; Frei, B.; Vita, J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104, 151–156.
55. Erba, D.; Riso, P.; Bordoni, A.; Foti, P.; Biagi, P.L.; Testolin, G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J. Nutr. Biochem. 2005, 16, 144-149.
56. Esser, D.; Mars, M.; Oosterink, E.; Stalmach, A.; Muller, M.; Afman, L.A. Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men. FASEB J. 2014, 28, 1464-1473.
57. Farouque, H.M.; Leung, M.; Hope, S.A.; Baldi, M.; Schechter, C.; Cameron, J.D.; Meredith, I.T. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: A randomized double-blind placebo-controlled study. Clin. Sci. 2006, 111, 71–80.
58. Flammer, A.J.; Sudano, I.; Wolfrum, M.; Thomas, R.; Enseleit, F.; Periat, D.; Kaiser, P.; Hirt, A.; Hermann, M.; Serafini, M. et al. Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur. Heart J. 2012, 33, 2172–2180.
59. Frank, J.; George, T.W.; Lodge, J.K.; Rodriguez-Mateos, A.M.; Spencer, J.P.; Minihane, A.M.; Rimbach, G. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J. Nutr. 2009, 139, 58–62.
60. Freese, R.; Basu, S.; Hietanen, E.; Nair, J.; Nakachi, K.; Bartsch, H.; Mutanen, M. Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur. J. Nutr. 1999, 38, 149–157.
61. Fu, D.; Ryan, E.P.; Huang, J.; Liu, Z.; Weir, T.L.; Snook, R.L.; Ryan, T.P. Fermented camellia sinensis, fu zhuan tea, regulates hyperlipidemia and transcription factors involved in lipid catabolism. Food Res. Int. 2011, 44, 2999–3005.
62. Fujita, H.; Yamagami, T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr. Res. 2008, 28, 450–456.
63. Fukino, Y.; Ikeda, A.; Maruyama, K.; Aoki, N.; Okubo, T.; Iso, H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur. J. Clin. Nutr. 2008, 62, 953–960.
64. Grassi, D.; Lippi, C.; Necozione, S.; Desideri, G.; Ferri, C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 2005, 81, 611–614.
65. Grassi, D.; Necozione, S.; Lippi, C.; Croce, G.; Valeri, L.; Pasqualetti, P.; Desideri, G.; Blumberg, J.B.; Ferri, C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005, 46, 398–405.
66. Hodgson, J.M.; Croft, K.D.; Woodman, R.J.; Puddey, I.B.; Fuchs, D.; Draijer, R.; Lukoshkova, E.; Head, G.A. Black tea lowers the rate of blood pressure variation: A randomized controlled trial. Am. J. Clin. Nutr. 2013, 97, 943–950.
67. Hodgson, J.M.; Puddey, I.B.; Burke, V.; Watts, G.F.; Beilin, L.J. Regular ingestion of black tea improves brachial artery vasodilator function. Clin. Sci. 2002, 102, 195–201.
68. Hsu, C.H.; Liao, Y.L.; Lin, S.C.; Tsai, T.H.; Huang, C.J.; Chou, P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 2011, 16, 157–163.
69. Hsu, C.H.; Tsai, T.H.; Kao, Y.H.; Hwang, K.C.; Tseng, T.Y.; Chou, P. Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2008, 27, 363–370.
70. Hsu, T.F.; Kusumoto, A.; Abe, K.; Hosoda, K.; Kiso, Y.; Wang, M.F.; Yamamoto, S. Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur. J. Clin. Nutr. 2006, 60, 1330–1336.
71. Hursel, R.; Westerterp-Plantenga, M.S. Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss. Am. J. Clin. Nutr. 2009, 89, 822-830.
72. Ibero-Baraibar, I.; Abete, I.; Navas-Carretero, S.; Massis-Zaid, A.; Martinez, J.A.; Zulet, M.A. Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 416–422.
73. Ichinose, T.; Nomura, S.; Someya, Y.; Akimoto, S.; Tachiyashiki, K.; Imaizumi, K. Effect of endurance training supplemented with green tea extract on substrate metabolism during exercise in humans. Scand. J. Med. Sci. Sports 2011, 21, 598–605.
74. Inami, S.; Takano, M.; Yamamoto, M.; Murakami, D.; Tajika, K.; Yodogawa, K.; Yokoyama, S.; Ohno, N.; Ohba, T.; Sano, J. et al. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int. Heart J. 2007, 48, 725–732.
75. Ishikawa, T.; Suzukawa, M.; Ito, T.; Yoshida, H.; Ayaori, M.; Nishiwaki, M.; Yonemura, A.; Hara, Y.; Nakamura, H. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 1997, 66, 261–266.
76. Kajimoto, O.; Kajimoto, Y.; Yabune, M.; Nakamura, T.; Kotani, K.; Suzuki, Y.; Nozawa, A.; Nagata, K.; Unno, T.; Sagesaka, Y.M. et al. Tea catechins with a galloyl moiety reduce body weight and fat. J. Health Sci. 2005, 51, 161–171.
77. Kajimoto, O.; Kajimoto, Y.; Yabune, M.; Nozawa, A.; Nagata, K.; Kakuda, T. Tea catechins reduce serum cholesterol levels in mild and borderline hypercholesterolemia patients. J. Clin. Biochem. Nutr. 2003, 33, 101–111.
78. Koutelidakis, A.E.; Rallidis, L.; Koniari, K.; Panagiotakos, D.; Komaitis, M.; Zampelas, A.; Anastasiou-Nana, M.; Kapsokefalou, M. Effect of green tea on postprandial antioxidant capacity, serum lipids, c-reactive protein and glucose levels in patients with coronary artery disease. Eur. J. Nutr. 2014, 53, 479–486.
79. Kovacs, E.M.; Lejeune, M.P.; Nijs, I.; Westerterp-Plantenga, M.S. Effects of green tea on weight maintenance after body-weight loss. Br. J. Nutr. 2004, 91, 431–437.
80. Lettieri-Barbato, D.; Villaño, D.; Beheydt, B.; Guadagni, F.; Trogh, I.; Serafini, M. Effect of ingestion of dark chocolates with similar lipid composition and different cocoa content on antioxidant and lipid status in healthy humans. Food Chem. 2012, 132, 1305–1310.
81. Liu, C.Y.; Huang, C.J.; Huang, L.H.; Chen, I.J.; Chiu, J.P.; Hsu, C.H. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: A randomized, double-blinded, and placebo-controlled trial. PLoS ONE 2014, 9, e91163.
82. Mahler, A.; Steiniger, J.; Bock, M.; Klug, L.; Parreidt, N.; Lorenz, M.; Zimmermann, B.F.; Krannich, A.; Paul, F.; Boschmann, M. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial. Am. J. Clin. Nutr. 2015, 101, 487–495.
83. Maki, K.C.; Reeves, M.S.; Farmer, M.; Yasunaga, K.; Matsuo, N.; Katsuragi, Y.; Komikado, M.; Tokimitsu, I.; Wilder, D.; Jones, F. et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J. Nutr. 2009, 139, 264–270.
84. Mastroiacovo, D.; Kwik-Uribe, C.; Grassi, D.; Necozione, S.; Raffaele, A.; Pistacchio, L.; Righetti, R.; Bocale, R.; Lechiara, M.C.; Marini, C. et al. Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: The cocoa, cognition, and aging (cocoa) study--a randomized controlled trial. Am. J. Clin. Nutr. 2015, 101, 538–548.
85. Matsuyama, T.; Tanaka, Y.; Kamimaki, I.; Nagao, T.; Tokimitsu, I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obes. Silver Spring 2008, 16, 1338–1348.
86. Mellor, D.D.; Sathyapalan, T.; Kilpatrick, E.S.; Beckett, S.; Atkin, S.L. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet. Med. 2010, 27, 1318–1321.
87. Mielgo-Ayuso, J.; Barrenechea, L.; Alcorta, P.; Larrarte, E.; Margareto, J.; Labayen, I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial. Br. J. Nutr. 2014, 111, 1263–1271.
88. Mirzaei, K.; Hossein-Nezhad, A.; Karimi, M.; Hosseinzadeh-Attar, M.J.; Jafari, N.; Najmafshar, A.; Larijani, B. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; a double- blind, placebo-controlled clinical trial study. DARU J. Pharm. Sci. 2009, 17, 38–44.
89. Miyazaki, R.; Kotani, K.; Ayabe, M.; Tsuzaki, K.; Shimada, J.; Sakane, N.; Takase, H.; Ichikawa, H.; Yonei, Y.; Ishii, K. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: A randomized controlled trial. Geriatr. Gerontol. Int. 2013, 13, 622–629.
90. Mogollon, J.A.; Bujold, E.; Lemieux, S.; Bourdages, M.; Blanchet, C.; Bazinet, L.; Couillard, C.; Noel, M.; Dodin, S. Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: A pilot, randomized controlled trial. Nutr. J. 2013, 12, 41, doi:10.1186/1475-2891-12-41.
91. Monagas, M.; Khan, N.; Andres-Lacueva, C.; Casas, R.; Urpi-Sarda, M.; Llorach, R.; Lamuela-Raventos, R.M.; Estruch, R. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr. 2009, 90, 1144–1150.
92. Monahan, K.D.; Feehan, R.P.; Kunselman, A.R.; Preston, A.G.; Miller, D.L.; Lott, M.E.J. Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J. Appl. Physiol. 2011, 111, 1568–1574.
93. Mousavi, A.; Vafa, M.; Neyestani, T.; Khamseh, M.; Hoseini, F. The effects of green tea consumption on metabolic and anthropometric indices in patients with type 2 diabetes. J. Res. Med. Sci. 2013, 18, 1080–1086.
94. Mozaffari-Khosravi, H.; Jalali-Khanabadi, B.A.; Afkhami-Ardekani, M.; Fatehi, F. Effects of sour tea (hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type ii diabetes. J. Altern. Complement. Med. 2009, 15, 899–903.
95. Muniyappa, R.; Hall, G.; Kolodziej, T.L.; Karne, R.J.; Crandon, S.K.; Quon, M.J. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am. J. Clin. Nutr. 2008, 88, 1685–1696.
96. Murphy, K.J.; Chronopoulos, A.K.; Singh, I.; Francis, M.A.; Moriarty, H.; Pike, M.J.; Turner, A.H.; Mann, N.J.; Sinclair, A.J. Dietary flavanols and procyanidin oligomers from cocoa (theobroma cacao) inhibit platelet function. Am. J. Clin. Nutr. 2003, 77, 1466–1473.
97. Nagao, T.; Hase, T.; Tokimitsu, I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obes. Silver Spring 2007, 15, 1473–1483.
98. Nagao, T.; Komine, Y.; Soga, S.; Meguro, S.; Hase, T.; Tanaka, Y.; Tokimitsu, I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am. J. Clin. Nutr. 2005, 81, 122–129.
99. Nagao, T.; Meguro, S.; Hase, T.; Otsuka, K.; Komikado, M.; Tokimitsu, I.; Yamamoto, T.; Yamamoto, K. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obes. Silver Spring 2009, 17, 310–317.
100. Nagasako-Akazome, Y.; Kanda, T.; Ohtake, Y.; Shimasaki, H.; Kobayashi, T. Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J. Oleo Sci. 2007, 56, 417-428.
101. Nantz, M.P.; Rowe, C.A.; Bukowski, J.F.; Percival, S.S. Standardized capsule of camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009, 25, 147–154.
102. Nickols-Richardson, S.M.; Piehowski, K.E.; Metzgar, C.J.; Miller, D.L.; Preston, A.G. Changes in body weight, blood pressure and selected metabolic biomarkers with an energy-restricted diet including twice daily sweet snacks and once daily sugar-free beverage. Nutr. Res. Pract. 2014, 8, 695–704.
103. Njike, V.Y.; Faridi, Z.; Shuval, K.; Dutta, S.; Kay, C.D.; West, S.G.; Kris-Etherton, P.M.; Katz, D.L. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int. J. Cardiol. 2011, 149, 83–88.
104. Oi, Y.; Fujita, H. Body weight and body mass index (bmi) in preobese and overweight japanese adults treated with black chinese tea water extract (bte) using a more appropriate statistical analysis method. Int. J. Food Prop. 2015, 18, 1345–1349.
105. Osakabe, N.; Baba, S.; Yasuda, A.; Iwamoto, T.; Kamiyama, M.; Tokunaga, T.; Kondo, K. Dose-response study of daily cocoa intake on the oxidative susceptibility of low-density lipoprotein in healthy human volunteers. J. Health Sci. 2004, 50, 679–684.
106. Parsaeyan, N.; Mozaffari-Khosravi, H.; Absalan, A.; Mozayan, M.R. Beneficial effects of cocoa on lipid peroxidation and inflammatory markers in type 2 diabetic patients and investigation of probable interactions of cocoa active ingredients with prostaglandin synthase-2 (ptgs-2/cox-2) using virtual analysis. J. Diabetes Metab. Disord. 2014, 13, 30, doi:10.1186/2251-6581-13-30.
107. Ravn-Haren, G.; Dragsted, L.O.; Buch-Andersen, T.; Jensen, E.N.; Jensen, R.I.; Nemeth-Balogh, M.; Paulovicsova, B.; Bergstrom, A.; Wilcks, A.; Licht, T.R. et al. Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers. Eur. J. Nutr. 2013, 52, 1875–1889.
108. Rostami, A.; Khalili, M.; Haghighat, N.; Eghtesadi, S.; Shidfar, F.; Heidari, I.; Ebrahimpour-Koujan, S.; Eghtesadi, M. High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension. ARYA Atheroscler. 2015, 11, 21–29.
109. Rull, G.; Mohd-Zain, Z.N.; Shiel, J.; Lundberg, M.H.; Collier, D.J.; Johnston, A.; Warner, T.D.; Corder, R. Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation. Vasc. Pharmacol. 2015, 71, 70–78.
110. Ryu, O.H.; Lee, J.; Lee, K.W.; Kim, H.Y.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Baik, S.H.; Choi, D.S.; Choi, K.M. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res. Clin. Pract. 2006, 71, 356–358.
111. Sansone, R.; Rodriguez-Mateos, A.; Heuel, J.; Falk, D.; Schuler, D.; Wagstaff, R.; Kuhnle, G.G.; Spencer, J.P.; Schroeter, H.; Merx, M.W. et al. Cocoa flavanol intake improves endothelial function and framingham risk score in healthy men and women: A randomised, controlled, double-masked trial: The flaviola health study. Br. J. Nutr. 2015, 114, 1246–1255.
112. Shiina, Y.; Funabashi, N.; Lee, K.; Murayama, T.; Nakamura, K.; Wakatsuki, Y.; Daimon, M.; Komuro, I. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic doppler echocardiography in healthy adults. Int. J. Cardiol. 2009, 131, 424–429.
113. Shimada, K.; Kawarabayashi, T.; Tanaka, A.; Fukuda, D.; Nakamura, Y.; Yoshiyama, M.; Takeuchi, K.; Sawaki, T.; Hosoda, K.; Yoshikawa, J. Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease. Diabetes Res. Clin. Pract. 2004, 65, 227–234.
114. Sone, T.; Kuriyama, S.; Nakaya, N.; Hozawa, A.; Shimazu, T.; Nomura, K.; Rikimaru, S.; Tsuji, I. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr. Res. 2011, 55, doi:10.3402/fnr.v55i0.8326.
115. Stendell-Hollis, N.R.; Thomson, C.A.; Thompson, P.A.; Bea, J.W.; Cussler, E.C.; Hakim, I.A. Green tea improves metabolic biomarkers, not weight or body composition: A pilot study in overweight breast cancer survivors. J. Hum. Nutr. Diet. 2010, 23, 590–600.
116. Suliburska, J.; Bogdanski, P.; Szulinska, M.; Stepien, M.; Pupek-Musialik, D.; Jablecka, A. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol. Trace Elem. Res. 2012, 149, 315–322.
117. Takahashi, M.; Miyashita, M.; Suzuki, K.; Bae, S.R.; Kim, H.K.; Wakisaka, T.; Matsui, Y.; Takeshita, M.; Yasunaga, K. Acute ingestion of catechin-rich green tea improves postprandial glucose status and increases serum thioredoxin concentrations in postmenopausal women. Br. J. Nutr. 2014, 112, 1542–1550.
118. Taubert, D.; Roesen, R.; Lehmann, C.; Jung, N.; Schomig, E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: A randomized controlled trial. JAMA 2007, 298, 49–60.
119. Tinahones, F.J.; Rubio, M.A.; Garrido-Sanchez, L.; Ruiz, C.; Gordillo, E.; Cabrerizo, L.; Cardona, F. Green tea reduces LDL oxidability and improves vascular function. J. Am. Coll. Nutr. 2008, 27, 209–213.
120. Toolsee, N.A.; Aruoma, O.I.; Gunness, T.K.; Kowlessur, S.; Dambala, V.; Murad, F.; Googoolye, K.; Daus, D.; Indelicato, J.; Rondeau, P. et al. Effectiveness of green tea in a randomized human cohort: Relevance to diabetes and its complications. Biomed. Res. Int. 2013, 2013, 412379.
121. Troup, R.; Hayes, J.H.; Raatz, S.K.; Thyagarajan, B.; Khaliq, W.; Jacobs, D.R., Jr.; Key, N.S.; Morawski, B.M.; Kaiser, D.; Bank, A.J. et al. Effect of black tea intake on blood cholesterol concentrations in individuals with mild hypercholesterolemia: A diet-controlled randomized trial. J. Acad. Nutr. Diet. 2015, 115, 264–271.e2.
122. Tsai Ch, H.; Chiu, W.C.; Yang, N.C.; Ouyang, C.M.; Yen, Y.H. A novel green tea meal replacement formula for weight loss among obese individuals: A randomized controlled clinical trial. Int. J. Food Sci. Nutr. 2009, 60 (Suppl 6), 151–159.
123. Tzounis, X.; Rodriguez-Mateos, A.; Vulevic, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am. J. Clin. Nutr. 2011, 93, 62–72.
124. Unno, T.; Tago, M.; Suzuki, Y.; Nozawa, A.; Sagesaka, Y.M.; Kakuda, T.; Egawa, K.; Kondo, K. Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br. J. Nutr. 2005, 93, 543–547.
125. Vafa, M.R.; Haghighatjoo, E.; Shidfar, F.; Afshari, S.; Gohari, M.R.; Ziaee, A. Effects of apple consumption on lipid profile of hyperlipidemic and overweight men. Int. J. Prev. Med. 2011, 2, 94–100.
126. Velliquette, R.A.; Grann, K.; Missler, S.R.; Patterson, J.; Hu, C.; Gellenbeck, K.W.; Scholten, J.D.; Randolph, R.K. Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial. Nutr. Metab. 2015, 12, 27, doi:10.1186/s12986-015-0025-2.
127. Vieira Senger, A.E.; Schwanke, C.H.; Gomes, I.; Valle Gottlieb, M.G. Effect of green tea (camellia sinensis) consumption on the components of metabolic syndrome in elderly. J. Nutr. Health Aging 2012, 16, 738–742.
128. Villaño, D.; Pecorari, M.; Testa, M.F.; Raguzzini, A.; Stalmach, A.; Crozier, A.; Tubili, C.; Serafini, M. Unfermented and fermented rooibos teas (aspalathus linearis) increase plasma total antioxidant capacity in healthy humans. Food Chem. 2010, 123, 679–683.
129. Vlachopoulos, C.; Aznaouridis, K.; Alexopoulos, N.; Economou, E.; Andreadou, I.; Stefanadis, C. Effect of dark chocolate on arterial function in healthy individuals. Am. J. Hypertens. 2005, 18, 785–791.
130. Wang, H.; Wen, Y.; Du, Y.; Yan, X.; Guo, H.; Rycroft, J.A.; Boon, N.; Kovacs, E.M.; Mela, D.J. Effects of catechin enriched green tea on body composition. Obes. Silver Spring 2010, 18, 773–779.
131. West, S.G.; McIntyre, M.D.; Piotrowski, M.J.; Poupin, N.; Miller, D.L.; Preston, A.G.; Wagner, P.; Groves, L.F.; Skulas-Ray, A.C. Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. Br. J. Nutr. 2014, 111, 653–661.
132. Westphal, S.; Luley, C. Flavanol-rich cocoa ameliorates lipemia-induced endothelial dysfunction. Heart Vessel. 2011, 26, 511–515.
133. Widlansky, M.E.; Hamburg, N.M.; Anter, E.; Holbrook, M.; Kahn, D.F.; Elliott, J.G.; Keaney, J.F., Jr.; Vita, J.A. Acute egcg supplementation reverses endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Nutr. 2007, 26, 95–102.
134. Widmer, R.J.; Freund, M.A.; Flammer, A.J.; Sexton, J.; Lennon, R.; Romani, A.; Mulinacci, N.; Vinceri, F.F.; Lerman, L.O.; Lerman, A. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur. J. Nutr. 2013, 52, 1223–1231.
135. Wu, A.H.; Spicer, D.; Stanczyk, F.Z.; Tseng, C.C.; Yang, C.S.; Pike, M.C. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev. Res. 2012, 5, 393–402.
136. Yang, H.Y.; Yang, S.C.; Chao, J.C.; Chen, J.R. Beneficial effects of catechin-rich green tea and inulin on the body composition of overweight adults. Br. J. Nutr. 2012, 107, 749–754.
137. Yang, T.Y.; Chou, J.I.; Ueng, K.C.; Chou, M.Y.; Yang, J.J.; Lin-Shiau, S.Y.; Hu, M.E.; Lin, J.K. Weight reduction effect of puerh tea in male patients with metabolic syndrome. Phytother. Res. 2014, 28, 1096–1101.
138. Li, Y.; Wang, C.; Huai, Q.; Guo, F.; Liu, L.; Feng, R.; Sun, C. Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: A meta-analysis of ten randomized controlled trials. Diabetes Metab. Res. Rev. 2016, 32, 2–10.
139. Zhao, Y.; Asimi, S.; Wu, K.; Zheng, J.; Li, D. Black tea consumption and serum cholesterol concentration: Systematic review and meta-analysis of randomized controlled trials. Clin. Nutr. 2015, 34, 612–619.
140. Zhong, X.; Zhang, T.; Liu, Y.; Wei, X.; Zhang, X.; Qin, Y.; Jin, Z.; Chen, Q.; Ma, X.; Wang, R. et al. Short-term weight-centric effects of tea or tea extract in patients with metabolic syndrome: A meta-analysis of randomized controlled trials. Nutr. Diabetes 2015, 5, e160, doi:10.1038/nutd.2015.10.
141. Wang, D.; Chen, C.; Wang, Y.; Liu, J.; Lin, R. Effect of black tea consumption on blood cholesterol: A meta-analysis of 15 randomized controlled trials. PLoS ONE 2014, 9, e107711.
142. Onakpoya, I.; Spencer, E.; Heneghan, C.; Thompson, M. The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 823–836.
143. Baladia, E.; Basulto, J.; Manera, M.; Martínez, R.; Calbet, D. Effect of green tea or green tea extract consumption on body weight and body composition; systematic review and meta-analysis. Nutr. Hosp. 2014, 29, 479–490.
144. Khalesi, S.; Sun, J.; Buys, N.; Jamshidi, A.; Nikbakht-Nasrabadi, E.; Khosravi-Boroujeni, H. Green tea catechins and blood pressure: A systematic review and meta-analysis of randomised controlled trials. Eur. J. Nutr. 2014, 53, 1299–311.
145. Hartley, L.; Flowers, N.; Holmes, J.; Clarke, A.; Stranges, S.; Hooper, L.; Rees, K. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, CD009934, doi:10.1002/14651858.CD009934.pub2.
146. Kim, A.; Chiu, A.; Barone, M.K.; Avino, D.; Wang, F.; Coleman, C.I.; Phung, O.J. Green tea catechins decrease total and low-density lipoprotein cholesterol: A systematic review and meta-analysis. J. Am. Diet. Assoc. 2011, 111, 1720–1729.
147. Zheng, X.X.; Xu, Y.L.; Li, S.H.; Liu, X.X.; Hui, R.; Huang, X.H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: A meta-analysis of 14 randomized controlled trials. Am. J. Clin. Nutr. 2011, 94, 601–610.
148. Phung, O.J.; Baker, W.L.; Matthews, L.J.; Lanosa, M.; Thorne, A.; Coleman, C.I. Effect of green tea catechins with or without caffeine on anthropometric measures: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2010, 91, 73–81.
149. Tokede, O.A.; Gaziano, J.M.; Djousse, L. Effects of cocoa products/dark chocolate on serum lipids: A meta-analysis. Eur. J. Clin. Nutr. 2011, 65, 879–886.
150. Lin, X.; Zhang, I.; Li, A.; Manson, J.E.; Sesso, H.D.; Wang, L.; Liu, S. Cocoa Flavanol Intake and Biomarkers for Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Nutr. 2016, 146, 2325–2333.
151. Hooper, L.; Kay, C.; Abdelhamid, A.; Kroon, P.A.; Cohn, J.S.; Rimm, E.B.; Cassidy, A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740–751.
152. De Pascual-Teresa, S.; Santos-Buelga, C.; Rivas-Gonzalo, J.C. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J. Agric. Food. Chem. 2000, 48, 5331–5337.
153. Hendijani, F.; Akbari, V. Probiotic supplementation for management of cardiovascular risk factors in adults with type ii diabetes: A systematic review and meta-analysis. Clin. Nutr. 2017, doi:10.1016/j.clnu.2017.02.015.
154. Zhang, Q.; Wu, Y.; Fei, X. Effect of probiotics on body weight and body-mass index: A systematic review and meta-analysis of randomized, controlled trials. Int. J. Food. Sci. Nutr. 2016, 67, 571–580.
155. Sugiyama, M.G.; Agellon, L.B. Sex differences in lipid metabolism and metabolic disease risk. Biochem. Cell Biol. 2012, 90, 124–141.
156. Wahi, G.; Anand, S.S. Race/ethnicity, obesity, and related cardio-metabolic risk factors: A life-course perspective. Curr. Cardiovasc. Risk Rep. 2013, 7, 326–335.
157. Chen, C.; Yu, X.; Shao, S. Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: A meta-analysis. PLoS ONE 2015, 10, e0139565.
158. Pereira, T.M.; Pimenta, F.S.; Porto, M.L.; Baldo, M.P.; Campagnaro, B.P.; Gava, A.L.; Meyrelles, S.S.; Vasquez, E.C. Coadjuvants in the diabetic complications: Nutraceuticals and drugs with pleiotropic effects. Int. J. Mol. Sci. 2016, 17, 1273, doi:10.3390/ijms17081273.
159. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Erlbaum: Hillsdale, NJ, USA, 1988.
160. Stelmach-Mardas, M.; Walkowiak, J. Dietary interventions and changes in cardio-metabolic parameters in metabolically healthy obese subjects: A systematic review with meta-analysis. Nutrients 2016, 8, 455, doi:10.3390/nu8080455.
161. Mead, E.; Atkinson, G.; Richter, B.; Metzendorf, M.I.; Baur, L.; Finer, N.; Corpeleijn, E.; O’Malley, C.; Ells, L.J. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst. Rev. 2016, 11, CD012436.
162. Mabire, L.; Mani, R.; Liu, L.; Mulligan, H.; Baxter, D. The influence of age, sex and body mass index on the effectiveness of brisk walking for obesity management in adults: A systematic review and meta-analysis. J. Phys. Act. Health 2017, 14, 389–407.
163. Peirson, L.; Fitzpatrick-Lewis, D.; Morrison, K.; Warren, R.; Usman Ali, M.; Raina, P. Treatment of overweight and obesity in children and youth: A systematic review and meta-analysis. CMAJ Open 2015, 3, E35–E46.
164. Kucukgoncu, S.; Zhou, E.; Lucas, K.B.; Tek, C. Alpha-lipoic acid (ala) as a supplementation for weight loss: Results from a meta-analysis of randomized controlled trials. Obes. Rev. 2017, 18, 594–601.
165. Zhang, Y.Y.; Liu, W.; Zhao, T.Y.; Tian, H.M. Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trials. J. Nutr. Health Aging 2017, 21, 187–192.
166. Taylor, F.; Huffman, M.D.; Macedo, A.F.; Moore, T.H.; Burke, M.; Davey Smith, G.; Ward, K.; Ebrahim, S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, CD004816, doi:10.1002/14651858.CD004816.pub5.
167. Sahebkar, A.; Serban, M.C.; Gluba-Brzozka, A.; Mikhailidis, D.P.; Cicero, A.F.; Rysz, J.; Banach, M. Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition 2016, 32, 1179–1192.
168. Silverman, M.G.; Ference, B.A.; Im, K.; Wiviott, S.D.; Giugliano, R.P.; Grundy, S.M.; Braunwald, E.; Sabatine, M.S. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis. JAMA 2016, 316, 1289–1297.
169. Samavat, H.; Newman, A.R.; Wang, R.; Yuan, J.M.; Wu, A.H.; Kurzer, M.S. Effects of green tea catechin extract on serum lipids in postmenopausal women: A randomized, placebo-controlled clinical trial. Am. J. Clin. Nutr. 2016, 104, 1671–1682.
170. Taub, P.R.; Ramirez-Sanchez, I.; Patel, M.; Higginbotham, E.; Moreno-Ulloa, A.; Roman-Pintos, L.M.; Phillips, P.; Perkins, G.; Ceballos, G.; Villarreal, F. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: Underlying mechanisms. A double blind, randomized, placebo controlled trial. Food Funct. 2016, 7, 3686–3693.
171. Lu, P.H.; Hsu, C.H. Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial. Complement. Ther. Med. 2016, 25, 159–163.
172. Dostal, A.M.; Arikawa, A.; Espejo, L.; Kurzer, M.S. Long-term supplementation of green tea extract does not modify adiposity or bone mineral density in a randomized trial of overweight and obese postmenopausal women. J. Nutr. 2016, 146, 256–264.
173. Most, J.; van Can, J.G.; van Dijk, J.W.; Goossens, G.H.; Jocken, J.; Hospers, J.J.; Bendik, I.; Blaak, E.E. A 3-day egcg-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects. Sci. Rep. 2015, 5, 17896.
174. Dostal, A.M.; Samavat, H.; Espejo, L.; Arikawa, A.Y.; Stendell-Hollis, N.R.; Kurzer, M.S. Green tea extract and catechol-o-methyltransferase genotype modify fasting serum insulin and plasma adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women. J. Nutr. 2016, 146, 38–45.
175. Basu, A.; Betts, N.M.; Leyva, M.J.; Fu, D.; Aston, C.E.; Lyons, T.J. Acute cocoa supplementation increases postprandial HDL cholesterol and insulin in obese adults with type 2 diabetes after consumption of a high-fat breakfast. J. Nutr. 2015, 145, 2325–2332.
176. Sarria, B.; Martinez-Lopez, S.; Sierra-Cinos, J.L.; Garcia-Diz, L.; Goya, L.; Mateos, R.; Bravo, L. Effects of bioactive constituents in functional cocoa products on cardiovascular health in humans. Food Chem. 2015, 174, 214–218.
177. Gutierrez-Salmean, G.; Meaney, E.; Lanaspa, M.A.; Cicerchi, C.; Johnson, R.J.; Dugar, S.; Taub, P.; Ramirez-Sanchez, I.; Villarreal, F.; Schreiner, G. et al. A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLC ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects. Int. J. Cardiol. 2016, 223, 500–506.
178. Imbe, H.; Sano, H.; Miyawaki, M.; Fujisawa, R.; Miyasato, M.; Nakatsuji, F.; Haseda, F.; Tanimoto, K.; Terasaki, J.; Maeda-Yamamoto, M. et al. “Benifuuki” green tea, containing o-methylated egcg, reduces serum low-density lipoprotein cholesterol and lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein b: A double-blind, placebo-controlled randomized trial. J. Funct. Foods 2016, 25, 25–37.
179. Lee, T.M.; Charng, M.J.; Tseng, C.D.; Lai, L.P. A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of sta-2 (green tea polyphenols) in patients with chronic stable angina. Acta Cardiol. Sin. 2016, 32, 439–449.
180. Ide, K.; Yamada, H.; Takuma, N.; Kawasaki, Y.; Harada, S.; Nakase, J.; Ukawa, Y.; Sagesaka, Y.M. Effects of green tea consumption on cognitive dysfunction in an elderly population: A randomized placebo-controlled study. Nutr. J. 2016, 15, 49, doi:10.1186/s12937-016-0168-7.
181. Mahmoud, F.; Haines, D.; Al-Ozairi, E.; Dashti, A. Effect of black tea consumption on intracellular cytokines, regulatory t cells and metabolic biomarkers in type 2 diabetes patients. Phytother. Res. 2016, 30, 454–462.
182. Ibero-Baraibar, I.; Suarez, M.; Arola-Arnal, A.; Zulet, M.A.; Martinez, J.A. Cocoa extract intake for 4 weeks reduces postprandial systolic blood pressure response of obese subjects, even after following an energy-restricted diet. Food Nutr. Res. 2016, 60, 30449.
183. Kobayashi, M.; Kawano, T.; Ukawa, Y.; Sagesaka, Y.M.; Fukuhara, I. Green tea beverages enriched with catechins with a galloyl moiety reduce body fat in moderately obese adults: A randomized double-blind placebo-controlled trial. Food Funct. 2016, 7, 498–507.